Onconova Therapeutics, Inc. (ONTX) NASDAQ
1.00
-0.0047(-0.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.00
-0.0047(-0.47%)
Currency In USD
| Market Cap | 5.43M |
| Enterprise Value | -3.81B |
| P/E Ratio | -2.7 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 3.44 |
| Price/Book Ratio | -15.7 |
| Enterprise/Revenue | 2.07 |
| Enterprise/EBITDA | -0.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.31 |
| Operating Margin | -1.9 |
| Return On Assets | -0.34 |
| Return On Equity | -0.96 |
| Revenue | 2.79B |
| Revenue/Share | 0.34 |
| Gross Profit | 0 |
| EBITDA | -17.88M |
| Net Income | 9.17M |
| Diluted EPS | 0.82 |
| Total Cash | 3.82B |
| Total Cash/Share | 0.46 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.72 |
| Book Value Per Share | -0.08 |
| 52-Week Change | -6.98 |
| 52-Week High | 1.45 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.82 |
| Moving Average 200 Days | 0.78 |
| Average Volume | 126,338 |
| Shares Outstanding | 21M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | May 21, 2021 |